Biruh T Workeneh

Biruh T Workeneh is an Associate Professor at The University of Texas MD Anderson Cancer Center, specializing in nephrology and onco-nephrology. His research focuses on chronic kidney disease, renal pathology, and electrolyte abnormalities in cancer patients, with particular emphasis on paraneoplastic syndromes, amyloidosis, and chemotherapy-associated nephrotoxicity. He has contributed to landmark clinical trials, including phase 2 studies of TRPC6 inhibition for focal segmental glomerulosclerosis and obinutuzumab in systemic lupus erythematosus, published in The Lancet and the New England Journal of Medicine. His recent work explores sodium-glucose cotransporter 2 inhibitors for cisplatin-associated nephrotoxicity and novel therapies for IgA nephropathy, advancing renal care in oncology.